---
figid: PMC8869227__biomolecules-12-00322-g004
figtitle: Cytoplasmic and Nuclear Functions of cIAP1
organisms:
- Mus musculus
- Rattus norvegicus
- Human gammaherpesvirus 4
- Cydia pomonella granulovirus
- Homo sapiens
- Saccharomyces cerevisiae
- Drosophila melanogaster
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Drosophila melanogaster
- Danio rerio
pmcid: PMC8869227
filename: biomolecules-12-00322-g004.jpg
figlink: /pmc/articles/PMC8869227/figure/biomolecules-12-00322-f004/
number: F4
caption: 'Regulation of signaling pathways by cIAP1. The cIAP1-TRAF2 E3-Ubiquitin
  ligase complex regulates the cellular content of NIK by mediating its ubiquitin-proteasome
  dependent degradation. The recruitment of cIAP1/TRAF2 to TNFR2, CD30, CD40 or BAFF-R
  releases NIK that in turn stimulates the non-canonical NF-κB signaling pathway.
  In the TLR4-associated signaling complex, cIAP1 induces the ubiquitination and degradation
  of TRAF3. cIAP1/TRAF2 forms a secondary cytoplasmic complex leading to NF-kB / MAPK
  activation. In TNFR1-associated complex, cIAP1 induces the ubiquitination of RIP1
  and other components of the complex, resulting in the assembly of the signaling
  platform driving NF-κB and MAPK activation. cIAP1-mediated ubiquitination of RIP1
  inhibits its kinase activity required for the assembly of cytoplasmic RIP-containing
  platforms leading to apoptotic or necrotic cell death. cIAP1 controls the cycle
  of activation of cdc42. The recruitment of cIAP1/TRAF2 to TNFR-associated signaling
  complex releases cdc42 for activation. BAFF-R: B-cell activating factor receptor;
  CD40-R: Cluster of differentiation 40 receptor, IKKα, β or γ: Inhibitor of κB kinase
  α, β or γ; LUBAC: linear ubiquitin chain assembly complex; Myd88: Myeloid differentiation
  primary response 88; NIK: NF-κB-inducing kinase; Rho-GDI: Rho-guanine-nucleotide
  dissociation inhibitors; TAB1, 2 or 3: transforming growth factor-activated kinase1-binding
  protein 1, 2, and 3; TAK1:tumor growth factor-β-activated kinase 1; TLR 4: toll-like
  receptor 4; TNFR2: tumor necrosis factor Receptor 2, TRADD: TNFR-associated death
  domain; TRIF: toll–interleukin 1 receptor domain-containing adaptor inducing IFN-β.'
papertitle: Cytoplasmic and Nuclear Functions of cIAP1.
reftext: Aymeric Zadoroznyj, et al. Biomolecules. 2022 Feb;12(2):322.
year: '2022'
doi: 10.3390/biom12020322
journal_title: Biomolecules
journal_nlm_ta: Biomolecules
publisher_name: MDPI
keywords: IAPs | signaling pathways | innate immunity | ubiquitination | TNFα | NF-κB
  | cell migration | E2F1
automl_pathway: 0.8439689
figid_alias: PMC8869227__F4
figtype: Figure
redirect_from: /figures/PMC8869227__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8869227__biomolecules-12-00322-g004.html
  '@type': Dataset
  description: 'Regulation of signaling pathways by cIAP1. The cIAP1-TRAF2 E3-Ubiquitin
    ligase complex regulates the cellular content of NIK by mediating its ubiquitin-proteasome
    dependent degradation. The recruitment of cIAP1/TRAF2 to TNFR2, CD30, CD40 or
    BAFF-R releases NIK that in turn stimulates the non-canonical NF-κB signaling
    pathway. In the TLR4-associated signaling complex, cIAP1 induces the ubiquitination
    and degradation of TRAF3. cIAP1/TRAF2 forms a secondary cytoplasmic complex leading
    to NF-kB / MAPK activation. In TNFR1-associated complex, cIAP1 induces the ubiquitination
    of RIP1 and other components of the complex, resulting in the assembly of the
    signaling platform driving NF-κB and MAPK activation. cIAP1-mediated ubiquitination
    of RIP1 inhibits its kinase activity required for the assembly of cytoplasmic
    RIP-containing platforms leading to apoptotic or necrotic cell death. cIAP1 controls
    the cycle of activation of cdc42. The recruitment of cIAP1/TRAF2 to TNFR-associated
    signaling complex releases cdc42 for activation. BAFF-R: B-cell activating factor
    receptor; CD40-R: Cluster of differentiation 40 receptor, IKKα, β or γ: Inhibitor
    of κB kinase α, β or γ; LUBAC: linear ubiquitin chain assembly complex; Myd88:
    Myeloid differentiation primary response 88; NIK: NF-κB-inducing kinase; Rho-GDI:
    Rho-guanine-nucleotide dissociation inhibitors; TAB1, 2 or 3: transforming growth
    factor-activated kinase1-binding protein 1, 2, and 3; TAK1:tumor growth factor-β-activated
    kinase 1; TLR 4: toll-like receptor 4; TNFR2: tumor necrosis factor Receptor 2,
    TRADD: TNFR-associated death domain; TRIF: toll–interleukin 1 receptor domain-containing
    adaptor inducing IFN-β.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TNFRSF1B
  - TNFRSF8
  - CD40
  - HMBS
  - TRAF2
  - TANK
  - TRAF3
  - BIRC2
  - MAP3K14
  - MAP4K4
  - MYD88
  - NFKB1
  - TLR4
  - TAB1
  - TAB2
  - TAB3
  - MAP3K7
  - NR2C2
  - TRIM69
  - TICAM1
  - UQCRFS1
  - RIPK1
  - RALBP1
  - KRR1
  - CHUK
  - IKBKB
  - IKBKG
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - TNFRSF1A
  - TRADD
  - CDC42
  - ARHGDIA
  - ARHGDIB
  - ARHGDIG
  - MTG1
  - Tnfrsf1a
  - Tnfrsf1b
  - Tnfrsf8
  - Cd40
  - Hmbs
  - Traf2
  - Traf3
  - Birc3
  - Birc2
  - Map4k4
  - Map3k14
  - Myd88
  - Nfkb1
  - Tlr4
  - Tab1
  - Tab2
  - Tab3
  - Nr2c2
  - Map3k7
  - Rnf138
  - Trim69
  - Ticam1
  - Ticam2
  - Ralbp1
  - Ripk1
  - Chuk
  - Ikbkb
  - Tradd
  - Cdc42
  - Arhgdia
  - Pck1
  - ups
  - Traf6
  - Traf-like
  - Ni-K
  - msn
  - Dif
  - dl
  - Rel
  - Toll-4
  - Tak1
  - IKKbeta
  - key
  - MKP-4
  - p38b
  - rl
  - RhoGDI
  - tnfrsf1b
  - cd40
  - traf3
  - myd88
  - tab1
  - tab2
  - tab3
  - ticam1
  - ripk1l
  - tradd
  - cdc42
  - cdc42l
---
